{"id":98367,"date":"2021-07-29T09:15:37","date_gmt":"2021-07-29T07:15:37","guid":{"rendered":"https:\/\/obera.fr\/conseils\/substances-cmr-risque-exposition-au-travail-quelle-reglementation-prevention\/"},"modified":"2025-05-07T09:34:29","modified_gmt":"2025-05-07T07:34:29","slug":"substances-cmr-risque-exposition-au-travail-quelle-reglementation-prevention","status":"publish","type":"post","link":"https:\/\/obera.fr\/tr\/bizim-tavsiyemiz\/substances-cmr-risque-exposition-au-travail-quelle-reglementation-prevention\/","title":{"rendered":"CMR maddeleri ve i\u015fyerinde maruz kalma riski: \u00f6nlemeye ili\u015fkin d\u00fczenlemeler nelerdir?"},"content":{"rendered":"\n<p>Baz\u0131 <strong>kimyasal maddelerin<\/strong> <strong>sa\u011fl\u0131k \u00fczerinde etkileri ve riskleri<\/strong> olabilir. Tek ba\u015flar\u0131na veya kar\u0131\u015f\u0131m halinde<strong> kanserojen, mutajenik veya insan \u00fcremesi i\u00e7in toksik<\/strong> olabilirler. Bunlar CMR maddeleri olarak bilinir. Bu maddeler temsil ettikleri tehlikeye g\u00f6re s\u0131n\u0131fland\u0131r\u0131l\u0131r. Bu kategorilerden sadece biri 2008 y\u0131l\u0131ndan beri bir Avrupa y\u00f6netmeli\u011fi kapsam\u0131ndad\u0131r (n\u00b01272\/2008-Eur-Lex).      <\/p>\n\n<p>Bu <strong>&#8220;CLP&#8221;<\/strong> (S\u0131n\u0131fland\u0131rma, Etiketleme ve Ambalajlama) <strong>y\u00f6netmeli\u011fidir<\/strong>. Frans\u0131z hukuku bu <strong>Avrupa y\u00f6netmeliklerini<\/strong>, \u00f6zellikle de \u0130\u015f Kanunu&#8217;nun R.4412-60 maddesindeki i\u015f hukukunu aktarm\u0131\u015ft\u0131r. Ger\u00e7ekten de, i\u015f\u00e7ilerin sa\u011fl\u0131k ve g\u00fcvenli\u011fi \u0130\u015f Kanunu&#8217;nun L4121-1 maddesinde tan\u0131nmaktad\u0131r. <strong>CMR maddeleri <\/strong> i\u00e7in bu d\u00fczenlemeler nelerdir?   <\/p>\n\n<h2 class=\"wp-block-heading\" id=\"substances-cmr-qu-est-ce-que-c-est\">CMR maddeleri: bunlar nelerdir?<\/h2>\n\n<p><strong>CMR maddeleri<\/strong> zararl\u0131 etkiler yaratan ve <strong>sa\u011fl\u0131k veya \u00e7evre i\u00e7in risk<\/strong> olu\u015fturan <strong>maddeler veya kar\u0131\u015f\u0131mlard\u0131r<\/strong>. Bu maddeler veya kar\u0131\u015f\u0131mlar soluma, yutma veya cilde n\u00fcfuz etme yoluyla risk olu\u015fturabilir: <\/p>\n\n<ul class=\"wp-block-list\">\n<li><strong>Kanserojen: kansere<\/strong> neden olan \u00fcr\u00fcnler.<\/li>\n\n\n\n<li><strong>Mutajenik<\/strong>: Kal\u0131tsal sorunlar \u00fcreten veya s\u0131kl\u0131\u011f\u0131n\u0131 on kat art\u0131ran.<\/li>\n\n\n\n<li><strong>Reprotoksik<\/strong>: \u00c7ocuklar \u00fczerinde kal\u0131tsal olmayan zararl\u0131 etkilerde art\u0131\u015f veya insan \u00fcreme kapasitesinde hasar.<\/li>\n<\/ul>\n\n<p>Farkl\u0131 <strong>kimyasal maddeler <\/strong>CMR \u00f6zelliklerine g\u00f6re s\u0131n\u0131fland\u0131r\u0131l\u0131r.<strong>INRS, CMR olarak s\u0131n\u0131fland\u0131r\u0131lan kimyasal maddelerin bir listesini sunmaktad\u0131r<\/strong>. Bu liste, maddelerin ana listesini, petrol ve k\u00f6m\u00fcrden elde edilen karma\u015f\u0131k maddelerin listesini, boyalar\u0131n listesini ve kar\u0131\u015f\u0131mlar i\u00e7in s\u0131n\u0131fland\u0131rma e\u015fiklerini i\u00e7eren bir tabloyu i\u00e7ermektedir. \u0130\u015fverenler, <strong>\u00e7al\u0131\u015fanlar\u0131n\u0131n sa\u011fl\u0131\u011f\u0131ndan<\/strong> ve <strong>sa\u011fl\u0131kl\u0131 bir \u00e7al\u0131\u015fma ortam\u0131<\/strong> sa\u011flamaktan sorumludur. Bu nedenle, bu maddeler hakk\u0131nda <a href=\"https:\/\/obera.fr\/tr\/bizim-tavsiyemiz\/reglementation-vlep-evaluation-risque-chimique-lieu-de-travail\/\" data-type=\"URL\" data-id=\"https:\/\/obera.fr\/conseils\/reglementation-vlep-evaluation-risque-chimique-lieu-de-travail\/\">VLEP (Valeurs limites d&#8217;exposition professionnelle &#8211; Mesleki Maruziyet S\u0131n\u0131r De\u011ferleri) y\u00f6netmeliklerinde<\/a> oldu\u011fu gibi bilgi edinmeleri gerekmektedir.    <\/p>\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>\u00c0 Lire aussi : <a href=\"https:\/\/obera.fr\/tr\/bizim-tavsiyemiz\/valeur-limite-exposition-professionnelle-ou-vlep\/\" data-type=\"post\" data-id=\"1999\">Mesleki Maruziyet S\u0131n\u0131r\u0131 Nedir?<\/a><\/p>\n<\/blockquote>\n\n<h2 class=\"wp-block-heading\" id=\"substances-cmr-quelles-sont-les-regles\">CMR maddeleri: kurallar nelerdir?<\/h2>\n\n<p><strong>Y\u00f6netmelik, bu CMR s\u0131n\u0131fland\u0131rmalar\u0131ndan yaln\u0131zca biriyle ilgilidir<\/strong>. <strong>CLP y\u00f6netmeli\u011fi<\/strong> (Eur-Lex n\u00b01272\/2008) <strong>sa\u011fl\u0131k ve \u00e7evrenin korunmas\u0131n\u0131<\/strong> ama\u00e7lamakta ve <strong>Avrupa&#8217;<\/strong>da yeknesakl\u0131\u011f\u0131 te\u015fvik etmektedir. Fransa bu CMR s\u0131n\u0131fland\u0131rmas\u0131n\u0131 iki kategoriye ay\u0131rm\u0131\u015ft\u0131r. <strong>Kategori 1 kanserojen, mutajenik veya reprotoksik risk ta\u015f\u0131yan \u00fcr\u00fcnlerle ilgilidir<\/strong>. Kategori 1 iki alt kategoriye ayr\u0131lm\u0131\u015ft\u0131r: CMR tehlikesi kan\u0131tlanm\u0131\u015f 1A ve CMR riski oldu\u011fu varsay\u0131lan 1B. <strong>Kategori 2, CMR riskinden \u015f\u00fcphelenilen \u00fcr\u00fcnleri kapsar<\/strong>.     <\/p>\n\n<h3 class=\"wp-block-heading\" id=\"comment-reconnaitre-un-produit-classe-cmr\">CMR olarak s\u0131n\u0131fland\u0131r\u0131lan bir \u00fcr\u00fcn\u00fc nas\u0131l tan\u0131rs\u0131n\u0131z?<\/h3>\n\n<p>Kanserojen, mutajen veya \u00fcreme i\u00e7in toksik olan \u00fcr\u00fcnleri belirlemek i\u00e7in <strong>tek <\/strong>bir <strong>risk de\u011ferlendirme belgesi <\/strong>mevcuttur. Bu belge, <strong>i\u015f faaliyetleriyle ili\u015fkili<\/strong> t\u00fcm <strong>riskleri<\/strong> listeler. Birka\u00e7 sayfa i\u00e7erir. CMR \u00fcr\u00fcnleri veya preparatlar\u0131<strong>etiketlerinden<\/strong> tan\u0131mlanabilir. Bunlar, \u00e7e\u015fitli risk uyar\u0131 ifadeleriyle birlikte &#8220;toksik&#8221; sembol\u00fcn\u00fc i\u00e7ermelidir (1182\/2020 say\u0131l\u0131 yeni bir Avrupa y\u00f6netmeli\u011fi kurallar\u0131 de\u011fi\u015ftirmi\u015ftir, ancak hen\u00fcz Fransa&#8217;da uygulanmam\u0131\u015ft\u0131r).      <\/p>\n\n<p>CMR \u00fcr\u00fcnlerinin \u00fcreticisi bir <strong>g\u00fcvenlik veri sayfas\u0131<\/strong> sa\u011flamal\u0131d\u0131r. \u00c7al\u0131\u015fanlar, kullan\u0131m i\u00e7in \u00fcr\u00fcn\u00fcn bile\u015fimini g\u00f6steren bu sayfaya eri\u015febilmelidir. Son olarak, i\u015fveren <strong>her \u00e7al\u0131\u015fan i\u00e7in<\/strong> bir <strong>maruziyet<\/strong> formu olu\u015fturmal\u0131d\u0131r. Bu formlar tehlikeli kimyasal maddelere ve CMR&#8217;lere maruz kal\u0131nan faaliyetlerin i\u00e7eri\u011fini, s\u00fcresini ve tekrarlanabilirli\u011fini kaydeder.   <\/p>\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>Daha fazla bilgi: <a href=\"https:\/\/obera.fr\/conseils\/vlep-quels-risques-cas-de-non-respect-reglementation\/\" data-type=\"URL\" data-id=\"https:\/\/obera.fr\/conseils\/vlep-quels-risques-cas-de-non-respect-reglementation\/\">VLEP&#8217;lere uymaman\u0131n riskleri nelerdir<\/a>?<\/p>\n<\/blockquote>\n\n<h3 class=\"wp-block-heading\" id=\"substances-cmr-quelle-est-la-prevention-au-travail\">CMR maddeleri: i\u015fyerinde \u00f6nleme ne olacak?<\/h3>\n\n<p><strong>CMR \u00fcr\u00fcnleri ve preparatlar\u0131n\u0131n<\/strong> ve daha genel olarak kimyasal risklerin <strong>\u00f6nlenmesinde<\/strong> i\u015fverenlerin de <strong>rol\u00fc<\/strong> vard\u0131r. Tehlikeli maddeleri ve CMR ajanlar\u0131n\u0131 zararl\u0131 olmayan veya daha az zararl\u0131 bir \u00fcr\u00fcnle de\u011fi\u015ftirmelidirler (Frans\u0131z \u0130\u015f Kanunu Madde R.4412-66). \u0130\u015fverenin kategori 1A veya 1B toksik \u00fcr\u00fcn\u00fcn <strong>yerine<\/strong> ge\u00e7ecek bir \u00fcr\u00fcn <strong>aramas\u0131<\/strong> esast\u0131r.  <\/p>\n\n<h3 class=\"wp-block-heading\" id=\"les-obligations-de-l-employeur-en-presence-de-substances-cmr-au-travail\">CMR maddelerinin i\u015fyerinde bulunmas\u0131 durumunda i\u015fverenin y\u00fck\u00fcml\u00fcl\u00fckleri<\/h3>\n\n<p><strong>\u0130kame, i\u015fverenin y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fcd\u00fcr<\/strong> ve bir CMR \u00fcr\u00fcn\u00fcn\u00fcn solunmas\u0131 veya yutulmas\u0131 riskini azaltmaya y\u00f6nelik di\u011fer t\u00fcm \u00f6nlemlerden \u00f6nceliklidir. \u015eirket, ba\u015far\u0131l\u0131 olsun ya da olmas\u0131n, att\u0131\u011f\u0131 ad\u0131mlar\u0131 gerek\u00e7elendirmelidir. <strong>Tek risk de\u011ferlendirme belgesi<\/strong> ara\u015ft\u0131rman\u0131n sonu\u00e7lar\u0131n\u0131 kaydeder. CMR ajanlar\u0131n\u0131n veya preparatlar\u0131n\u0131n ikame edilmemesini hakl\u0131 \u00e7\u0131karmak i\u00e7in teknik arg\u00fcmanlar kullan\u0131labilir. Bu durumda, i\u015fveren kanserojen, mutajen veya \u00fcreme i\u00e7in toksik maddelerin kapal\u0131 bir alanda kullan\u0131lmas\u0131n\u0131 sa\u011flamal\u0131d\u0131r (madde R.4412-68).    <\/p>\n\n<p>Obera&#8217;da, \u00e7al\u0131\u015fma alanlar\u0131n\u0131z i\u00e7in hava \u015fartland\u0131rma konusunda uzman\u0131z. CMR maddelerinin tehlikesine g\u00f6re uyarlanm\u0131\u015f ekipmanlar \u00f6nerebiliriz. Bizimle ileti\u015fime ge\u00e7mekten \u00e7ekinmeyin.  <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Baz\u0131 kimyasal maddeler tek ba\u015flar\u0131na veya kar\u0131\u015f\u0131m halinde kanserojen, mutajen veya insan \u00fcremesi i\u00e7in toksik olabilir. Bunlar CMR maddeleri olarak bilinir. Bu maddeler temsil ettikleri tehlikeye g\u00f6re s\u0131n\u0131fland\u0131r\u0131l\u0131r ve 2008 y\u0131l\u0131ndan beri bir Avrupa y\u00f6netmeli\u011fi (n\u00b01272\/2008-Eur-Lex) kapsam\u0131ndad\u0131r.     <\/p>\n","protected":false},"author":4,"featured_media":98292,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"none","_seopress_titles_title":"CMR maddeleri, i\u015fyerinde maruz kalma riski ve y\u00f6netmelikler","_seopress_titles_desc":"Kimyasal maddelerin sa\u011fl\u0131k \u00fczerinde etkileri ve riskleri olabilir. Kanserojen, mutajenik veya insan \u00fcremesi i\u00e7in toksik olabilirler. ","_seopress_robots_index":"","footnotes":""},"categories":[299],"tags":[306],"class_list":["post-98367","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bizim-tavsiyemiz","tag-entete-small-tr","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","no-featured-image-padding","resize-featured-image"],"acf":[],"_links":{"self":[{"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/posts\/98367","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/comments?post=98367"}],"version-history":[{"count":1,"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/posts\/98367\/revisions"}],"predecessor-version":[{"id":98370,"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/posts\/98367\/revisions\/98370"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/media\/98292"}],"wp:attachment":[{"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/media?parent=98367"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/categories?post=98367"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/obera.fr\/tr\/wp-json\/wp\/v2\/tags?post=98367"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}